Healthcare Triangle Inc
NASDAQ:HCTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Healthcare Triangle Inc
NASDAQ:HCTI
|
US |
|
R
|
RIX Corp
TSE:7525
|
JP |
|
O
|
Okamura Foods Co Ltd
TSE:2938
|
JP |
Income Statement
Earnings Waterfall
Healthcare Triangle Inc
Income Statement
Healthcare Triangle Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Revenue |
31
N/A
|
32
+2%
|
34
+8%
|
35
+2%
|
35
+1%
|
38
+9%
|
40
+4%
|
44
+10%
|
46
+5%
|
45
-3%
|
42
-7%
|
37
-10%
|
33
-11%
|
27
-17%
|
22
-20%
|
17
-24%
|
12
-29%
|
11
-3%
|
12
+5%
|
13
+9%
|
|
| Gross Profit | |||||||||||||||||||||
| Cost of Revenue |
(23)
|
(23)
|
(24)
|
(24)
|
(25)
|
(27)
|
(29)
|
(32)
|
(35)
|
(35)
|
(33)
|
(30)
|
(26)
|
(21)
|
(17)
|
(12)
|
(9)
|
(9)
|
(10)
|
(11)
|
|
| Gross Profit |
9
N/A
|
9
N/A
|
10
+16%
|
11
+7%
|
11
-1%
|
11
+7%
|
11
-2%
|
12
+6%
|
11
-4%
|
10
-12%
|
9
-12%
|
7
-20%
|
7
-4%
|
6
-8%
|
5
-17%
|
4
-19%
|
3
-31%
|
2
-24%
|
2
-18%
|
2
-6%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(7)
|
(8)
|
(10)
|
(12)
|
(16)
|
(18)
|
(20)
|
(21)
|
(22)
|
(22)
|
(21)
|
(18)
|
(13)
|
(16)
|
(15)
|
(13)
|
(8)
|
(7)
|
(6)
|
(8)
|
|
| Selling, General & Administrative |
(5)
|
(6)
|
(6)
|
(7)
|
(9)
|
(10)
|
(12)
|
(13)
|
(12)
|
(13)
|
(12)
|
(11)
|
(10)
|
(9)
|
(8)
|
(7)
|
(6)
|
(6)
|
(6)
|
(8)
|
|
| Research & Development |
(2)
|
(2)
|
(2)
|
(4)
|
(5)
|
(6)
|
(5)
|
(5)
|
(6)
|
(5)
|
(5)
|
(3)
|
(1)
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(2)
|
(7)
|
(7)
|
(6)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Operating Income |
1
N/A
|
0
-91%
|
0
+300%
|
(2)
N/A
|
(5)
-253%
|
(7)
-23%
|
(9)
-29%
|
(9)
-6%
|
(10)
-16%
|
(12)
-12%
|
(12)
-1%
|
(11)
+6%
|
(6)
+46%
|
(10)
-65%
|
(10)
+2%
|
(9)
+4%
|
(5)
+49%
|
(4)
+7%
|
(4)
+0%
|
(6)
-32%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
2
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Pre-Tax Income |
3
N/A
|
1
-44%
|
2
+12%
|
(1)
N/A
|
(6)
-998%
|
(7)
-20%
|
(8)
-10%
|
(8)
-4%
|
(10)
-18%
|
(11)
-13%
|
(12)
-13%
|
(12)
+3%
|
(9)
+27%
|
(11)
-26%
|
(11)
+2%
|
(10)
+7%
|
(6)
+40%
|
(6)
+3%
|
(6)
+2%
|
(6)
-12%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
|
| Income from Continuing Operations |
2
|
1
|
2
|
(1)
|
(6)
|
(7)
|
(8)
|
(8)
|
(10)
|
(11)
|
(12)
|
(12)
|
(9)
|
(11)
|
(11)
|
(10)
|
(6)
|
(6)
|
(6)
|
(6)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
2
N/A
|
1
-44%
|
2
+15%
|
(1)
N/A
|
(6)
-860%
|
(7)
-20%
|
(8)
-10%
|
(8)
-4%
|
(10)
-17%
|
(11)
-13%
|
(12)
-13%
|
(12)
+3%
|
(9)
+27%
|
(11)
-26%
|
(11)
+3%
|
(10)
+6%
|
(6)
+40%
|
(6)
+3%
|
(6)
+2%
|
(6)
-12%
|
|
| EPS (Diluted) |
9 038.46
N/A
|
5 038.46
-44%
|
5 807.69
+15%
|
-2 384.61
N/A
|
-29 750
-1 148%
|
-29 791.66
0%
|
-32 708.33
-10%
|
-34 166.66
-4%
|
-38 440
-13%
|
-38 857.14
-1%
|
-43 821.42
-13%
|
-42 392.85
+3%
|
-31 021.42
+27%
|
-36 413.33
-17%
|
-29 566.66
+19%
|
-26 192.1
+11%
|
-17 054.28
+35%
|
-8 798.48
+48%
|
-145.03
+98%
|
-85.36
+41%
|
|